Real-world data demonstrate that nirsevimab and maternal vaccination protect infants against severe RSV outcomes.

The age-adjusted suicide rate increased from 2014 to 2017 and then did not change significantly from 2017 through 2024.

MenB coverage was improved but still suboptimal among individuals aged 10 to 25 years who had high-risk conditions, with an overall initiation rate of 39%. Patients with asplenia were most likely to ...

Data presented at USCHA 2026 demonstrate that culturally-responsive campaigns significantly improve HIV PrEP awareness.

A large-scale testing initiative identified patients in the Puerto Rican correctional system with positive results for HIV ...

Disparities in pre-exposure prophylaxis access and routine screening continue to hinder national efforts to prevent and treat ...

Infectious Disease Advisor provides news updates and key opinion leader interviews from USCHA 2026, held in Anaheim, ...

Integrating community pharmacies into the HIV prevention landscape offers accessible, disease-agnostic entry points for PrEP ...

A mobile retail pharmacy and clinic model in Connecticut improves HIV care and substance use treatment for vulnerable ...

Updated BNT162b2 KP.2 vaccination reduces COVID-19 hospitalizations and ED visits in immunocompetent adults regardless of risk status.

Previous STI history is linked to increased current PrEP use, though uptake disparities remain across patient demographic ...

New legislative efforts seek to address housing instability and prevent discrimination against aging people living with HIV ...